CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
New, Novel Lipid-Lowering Agents for Reducing Cardiovascular Risk: Beyond Statins
Kyuho Kim, Henry N. Ginsberg, Sung Hee Choi
Diabetes Metab J. 2022;46(4):517-532.   Published online July 27, 2022

Excel Download

New, Novel Lipid-Lowering Agents for Reducing Cardiovascular Risk: Beyond Statins
Diabetes & Metabolism Journal. 2022;46(4):517-532   Crossref logo
Link1 Link2 Link3

Beyond Statins: New Lipid Lowering Strategies to Reduce Cardiovascular Risk
Current Atherosclerosis Reports. 2014;16(6):   Crossref logo
Link1 Link2 Link3

Lipid lowering beyond statins and methodological issues in cardiovascular clinical trials
European Heart Journal. 2022;43(14):1365-1368   Crossref logo
Link1 Link2

Statins and n-3 fatty acids are the best lipid-lowering interventions for reducing mortality
Evidence-based Cardiovascular Medicine. 2005;9(3):237-238   Crossref logo
Link1 Link2

A Look Beyond Statins and Ezetimibe: a Review of Other Lipid-Lowering Treatments for Cardiovascular Disease Prevention in High-Risk Patients
Current Cardiovascular Risk Reports. 2019;13(11):   Crossref logo
Link1 Link2 Link3

Cardiovascular effects of statins, beyond lipid-lowering properties
Pharmacological Research. 2014;88:12-19   Crossref logo
Link1 Link2

Current perspectives on lipid lowering with statins to decrease risk of cardiovascular disease
Clinical Cardiology. 2001;24(S2):2-5   Crossref logo
Link1 Link2

Beyond Lipid Lowering: The Anti-Hypertensive Role of Statins
Cardiovascular Drugs and Therapy. 2007;21(3):161-169   Crossref logo
Link1 Link2 Link3 Link4

Meta-analysis of the cardiovascular benefits of intensive lipid lowering with statins
Acta Neurologica Scandinavica. 2010;124(3):188-195   Crossref logo
Link1 Link2

The cost-effectiveness of lipid lowering for primary cardiovascular prevention in chronic kidney disease: moving beyond statins
Kidney International. 2019;96(1):22-25   Crossref logo
Link1 Link2